Sun Pharmaceutical Industries Ltd reported a 26% increase in its net profit for the fourth quarter, reaching ₹2,714 crore. The company's sales also grew by 13.6% to ₹14,559 crore during the same period. These results indicate a robust performance for Sun Pharma in the Indian pharmaceutical market, reflecting steady demand and operational efficiency. The growth in both profit and sales underscores the company's continued expansion and resilience in a competitive sector. Sales up 13.6% at ₹14,559 crore in the quarter under review. The update was published on 22 May 2026, 4:05 pm. Sun Pharmaceutical Industries Ltd remain central to this update.